Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Current Taxes: 2013-2024

Historic Current Taxes for Ani Pharmaceuticals (ANIP) over the last 7 years, with Dec 2024 value amounting to $6.7 million.

  • Ani Pharmaceuticals' Current Taxes was N/A to $3.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $6.7 million for FY2024, which is 17.33% down from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Current Taxes of $6.7 million as of FY2024, which was down 17.33% from $8.2 million recorded in FY2023.
  • Ani Pharmaceuticals' Current Taxes' 5-year high stood at $8.2 million during FY2023, with a 5-year trough of $3.9 million in FY2020.
  • For the 2-year period, Ani Pharmaceuticals' Current Taxes averaged around $7.5 million, with its median value being $7.5 million (2023).
  • Data for Ani Pharmaceuticals' Current Taxes shows a maximum YoY dropped of 17.33% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Ani Pharmaceuticals' Current Taxes stood at $3.9 million in 2020, then reached $8.2 million in 2023, then declined by 17.33% to $6.7 million in 2024.